Position history for Caption Management, LLC's holdings in CYTOKINETICS INC
Caption Management, LLC holds 245,000 shares of CYTK (CYTOKINETICS INC), worth $16.1M as of 2026-Q1. The position was increased (+775.0% shares). CYTK represents 0.1% of Caption Management, LLC's portfolio.
Current Value
$16.1M
Current Shares
245,000
Total Value Change
+$12.5M
Total Shares Change
+178,000
Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 245,000 |
+775.0% |
| $16.1M |
| 0.1% |
| $60.72 |
45 |
| 2025-Q4 | Decreased | 27,999 | -7.8% | $1.8M | 0.0% | $61.37 | 0 |
| 2025-Q3 | Increased | 30,357 | +59.8% | $1.7M | 0.0% | $53.89 | 37 |
| 2025-Q2 | Decreased | 19,000 | -67.7% | $627,760 | 0.0% | $33.16 | 0 |
| 2025-Q1 | Increased | 58,739 | +7.1% | $2.4M | 0.0% | $43.19 | 28 |
| 2024-Q4 | Increased | 54,830 | +63.7% | $2.6M | 0.0% | $47.15 | 38 |
| 2024-Q3 | Decreased | 33,500 | -50.0% | $1.8M | 0.0% | $52.34 | 0 |
| 2024-Q2 | Decreased | 67,000 | -74.8% | $3.6M | 0.1% | $54.18 | 0 |